# Normative Values for Cognitive Testing and Alzheimer's Imaging Biomarkers in Young Adults

> **NCT01609335** · PHASE1 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 41 (actual)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DRUG:** F-18 FDG
- **DRUG:** C-11 PiB

## Key facts

- **NCT ID:** NCT01609335
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2013-08
- **Final completion:** 2013-08
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2014-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01609335

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01609335, "Normative Values for Cognitive Testing and Alzheimer's Imaging Biomarkers in Young Adults". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01609335. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*